# Extracted content

URL: https://www.nice.org.uk/guidance/ta972
Saved: 2025-10-24T07:43:05.222283+00:00

---

## Overview

NICE is unable to make a recommendation on sirolimus (Hyftor) for treating facial angiofibroma caused by tuberous sclerosis complex in people 6 years and over. This is because Plusultra pharma did not provide an evidence submission. We will review this decision if the company decides to make a submission.